205 related articles for article (PubMed ID: 27036725)
21. The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers.
Powell N; Boyde A; Tristram A; Hibbitts S; Fiander A
Int J Cancer; 2009 Nov; 125(10):2425-7. PubMed ID: 19585507
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix.
Tornesello ML; Losito S; Benincasa G; Fulciniti F; Botti G; Greggi S; Buonaguro L; Buonaguro FM
Gynecol Oncol; 2011 Apr; 121(1):32-42. PubMed ID: 21211829
[TBL] [Abstract][Full Text] [Related]
23. Human Papillomavirus type distribution in invasive cervical cancer in Uganda.
Odida M; de Sanjosé S; Quint W; Bosch XF; Klaustermeier J; Weiderpass E
BMC Infect Dis; 2008 Jun; 8():85. PubMed ID: 18577214
[TBL] [Abstract][Full Text] [Related]
24. Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in India.
Pillai RM; Babu JM; Jissa VT; Lakshmi S; Chiplunkar SV; Patkar M; Tongaonkar H; Reddy KB; Chakka KN; Siddiqui M; Roychoudury S; Abraham P; Peedicayil A; Gnanamony M; Subashini J; Ram TS; Dey B; Singh N; Singh A; Jain SK; Jayshree RS
Int J Gynecol Cancer; 2010 Aug; 20(6):1046-51. PubMed ID: 20683415
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer in Ethiopia: a review of the literature.
Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
[TBL] [Abstract][Full Text] [Related]
26. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
[TBL] [Abstract][Full Text] [Related]
27. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.
Pérez-Castro S; Lorenzo-Mahía Y; Iñarrea Fernández A; Lamas-González MJ; Sarán-Díez MT; Rubio-Alarcón J; Reboredo-Reboredo MC; Mosteiro-Lobato S; López-Miragaya I; Torres-Piñón J; Melón-García S
Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):479-85. PubMed ID: 24274937
[TBL] [Abstract][Full Text] [Related]
28. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and distribution of high risk human papillomavirus (HPV) Types 16 and 18 in Carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India.
Kulkarni SS; Kulkarni SS; Vastrad PP; Kulkarni BB; Markande AR; Kadakol GS; Hiremath SV; Kaliwal S; Patil BR; Gai PB
Asian Pac J Cancer Prev; 2011; 12(3):645-8. PubMed ID: 21627358
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of high-risk human papillomaviruses type distribution in cervical cancer in Sichuan province of China.
Wu EQ; Zhang GN; Yu XH; Ren Y; Fan Y; Wu YG; Kong W; Zha X
BMC Cancer; 2008 Jul; 8():202. PubMed ID: 18644159
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer.
Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Christopher S; Gravitt P; Abraham P
Int J Gynecol Cancer; 2009 Nov; 19(8):1415-20. PubMed ID: 20009900
[TBL] [Abstract][Full Text] [Related]
32. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
33. Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.
Xu XX; Zhou JS; Yuan SH; Yu H; Lou HM
Int J Environ Res Public Health; 2015 Sep; 12(9):10794-805. PubMed ID: 26404339
[TBL] [Abstract][Full Text] [Related]
34. Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Yang R; Klimentová J; Göckel-Krzikalla E; Ly R; Gmelin N; Hotz-Wagenblatt A; Řehulková H; Stulík J; Rösl F; Niebler M
mSphere; 2019 Mar; 4(2):. PubMed ID: 30918060
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide.
Chen AA; Gheit T; Franceschi S; Tommasino M; Clifford GM;
J Virol; 2015 Oct; 89(20):10680-7. PubMed ID: 26269181
[TBL] [Abstract][Full Text] [Related]
36. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
37. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland.
Anderson LA; O'Rorke MA; Wilson R; Jamison J; Gavin AT;
J Med Virol; 2016 Jul; 88(7):1262-70. PubMed ID: 26680281
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.
Clifford GM; Tenet V; Georges D; Alemany L; Pavón MA; Chen Z; Yeager M; Cullen M; Boland JF; Bass S; Steinberg M; Raine-Bennett T; Lorey T; Wentzensen N; Walker J; Zuna R; Schiffman M; Mirabello L
Papillomavirus Res; 2019 Jun; 7():67-74. PubMed ID: 30738204
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
Debrah O; Agyemang-Yeboah F; Donkoh ET; Asmah RH
BMC Womens Health; 2021 Oct; 21(1):372. PubMed ID: 34702246
[TBL] [Abstract][Full Text] [Related]
40. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
